1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Molecular Diagnostics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Molecular Diagnostics Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Development of new products and increase in demand for point-or-care testing
5.2 Market Opportunities
- 5.2.1 Advancement in Molecular Diagnostics Technologies
5.3 Future Trends
- 5.3.1 Molecular Diagnostics in Personalized Medicine
5.4 Impact of Drivers and Restraints
6. North America Molecular Diagnostics Market Regional Analysis
6.1 North America Molecular Diagnostics Market Overview
6.2 North America Molecular Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 North America Molecular Diagnostics Market Forecast Analysis
7. North America Molecular Diagnostics Market Analysis – by Disease Area
7.1 Oncology
- 7.1.1 Overview
- 7.1.2 Oncology: North America Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Infectious Disease
- 7.2.1 Overview
- 7.2.2 Infectious Disease: North America Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Genetic Testing
- 7.3.1 Overview
- 7.3.2 Genetic Testing: North America Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Cardiac Diseases
- 7.4.1 Overview
- 7.4.2 Cardiac Diseases: North America Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Immune System Disorders
- 7.5.1 Overview
- 7.5.2 Immune System Disorders: North America Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Molecular Diagnostics Market Analysis – by Technology
8.1 Polymerase Chain Reaction
- 8.1.1 Overview
- 8.1.2 Polymerase Chain Reaction: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Isothermal Nucleic Acid Amplification Technology
- 8.2.1 Overview
- 8.2.2 Isothermal Nucleic Acid Amplification Technology: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 DNA Sequencing & Next-Generation Sequencing
- 8.3.1 Overview
- 8.3.2 DNA Sequencing & Next-Generation Sequencing: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 DNA Microarrays
- 8.4.1 Overview
- 8.4.2 DNA Microarrays: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 In-Situ Hybridization
- 8.5.1 Overview
- 8.5.2 In-Situ Hybridization: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Molecular Diagnostics Market Analysis – by Product and Services
9.1 Assays & Kits
- 9.1.1 Overview
- 9.1.2 In-Situ Hybridization: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Instruments
- 9.2.1 Overview
- 9.2.2 In-Situ Hybridization: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Services & Software
- 9.3.1 Overview
- 9.3.2 In-Situ Hybridization: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Molecular Diagnostics Market – North America Analysis
10.1 North America
- 10.1.1 North America Molecular Diagnostics Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 North America Molecular Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 US: North America Molecular Diagnostics Market Breakdown, by Disease Area
- 10.1.1.1.2 US: North America Molecular Diagnostics Market Breakdown, by Technology
- 10.1.1.1.3 US: North America Molecular Diagnostics Market Breakdown, by Product and Services
- 10.1.1.2 Canada:
North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Canada: North America Molecular Diagnostics Market Breakdown, by Disease Area
- 10.1.1.2.2 Canada: North America Molecular Diagnostics Market Breakdown, by Technology
- 10.1.1.2.3 Canada: North America Molecular Diagnostics Market Breakdown, by Product and Services
- 10.1.1.3 Mexico :
North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 Mexico : North America Molecular Diagnostics Market Breakdown, by Disease Area
- 10.1.1.3.2 Mexico : North America Molecular Diagnostics Market Breakdown, by Technology
- 10.1.1.3.3 Mexico : North America Molecular Diagnostics Market Breakdown, by Product and Services
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Molecular Diagnostics Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Agilent Technologies Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 bioMerieux SA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Danaher
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Illumina Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Novartis AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Qiagen NV
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Siemens Healthineers AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 TBG Diagnostics Limited
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Thermo Fisher Scientific Inc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Molecular Diagnostics Market
